Publications by authors named "Kevin A David"

Claim this Profile
O
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
Narendranath Epperla, Lei Feng, Nirav N Shah, Lindsey Fitzgerald, Harsh Shah, Kevin A David

J Hematol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, David A Bond

Am J Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, David A Bond

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, David M Weiner, Kevin A David

Blood Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL.
Deborah A Katz, Joan D Morris, Michael P Chu, Kevin A David, Catherine Thieblemont

Leuk Lymphoma· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, David M Weiner, Kevin A David

J Hematol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow, Kevin A David

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Integration of Nucleotide Metabolism Fatty Acid Synthase in Non-Hodgkin Lymphoma.
Dashnamoorthy Ravi, Afshin Beheshti, Nasséra Abermil, Frederick Lansigan, William Kinlaw, Kevin A David

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.
Victor M Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L Bartlett, Timothy J Voorhees, Kevin A David

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Adam S Zayac, Andrew M Evens, Alexey Danilov, Stephen D Smith, Deepa Jagadeesh, David A Bond, Kevin A David

Haematologica· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burkitt Lymphoma International Prognostic Index.
Adam J Olszewski, Lasse H Jakobsen, Graham P Collins, Kate Cwynarski, Veronika Bachanova, Kevin A David, David Peace

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
Reid W Merryman, Robert A Redd, Taiga Nishihori, Julio Chavez, Yago Nieto, David A Bond, Kevin A David

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Andrew M Evens, Alexey Danilov, Deepa Jagadeesh, Amy Sperling, Seo-Hyun Kim, David A Bond, Kevin A David

Blood· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial.
Catherine S Diefenbach, Fangxin Hong, Richard F Ambinder, Jonathon B Cohen, Michael J Robertson, Kevin A David, David S Morgan

Lancet Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches.
Mansi R Shah, Justin S Brandt, Kevin A David, Andrew M Evens

Curr Oncol Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Reid W Merryman, Nicole A Carreau, Ranjana H Advani, Michael A Spinner, Alex F Herrera, Kevin A David

Oncologist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment Options for Older Patients with Hodgkin Lymphoma.
Jordan Carter, Kevin A David, Athena Kritharis, Andrew M Evens

Curr Treat Options Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.
Frank C Passero, Dashnamoorthy Ravi, J Tyson McDonald, Afshin Beheshti, Kevin A David

Br J Haematol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Emily C Ayers, Shaoying Li, L Jeffrey Medeiros, David A Bond, Kami J Maddocks, Kevin A David

Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of older Hodgkin lymphoma patients.
Andrew M Evens, Jordan Carter, Kah Poh Loh, Kevin A David

Hematology Am Soc Hematol Educ Program· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?
Kevin A David, Athena Kritharis, Andrew M Evens

Lancet Haematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Studies in Hematologic Microtransplantation.
Kevin A David, Dennis Cooper, Roger Strair

Curr Hematol Malig Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).
Katherine Mallin, Kevin A David, Peter R Carroll, Matthew I Milowsky, David M Nanus

J Urol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.
Kevin A David, Nigel P Mongan, Christopher Smith, Lorraine J Gudas, David M Nanus

Cancer Biol Ther· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.
Andrew M Evens, Kevin A David, Irene Helenowski, Beverly Nelson, Dixon Kaufman

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis